Dolby Laboratories Reports First Quarter Fiscal 2016 Financial Results

Go back to Dolby Laboratories Reports First Quarter Fiscal 2016 Financial Results

Dougherty & Co Upgrades Dolby Laboratories (DLB) to Buy

January 28, 2016 6:59 AM EST

Dougherty & Co upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Buy with a price target of $38.

Analyst Steven Frankel said, "On the heels of a solid Q1 performance where the company posted 3% revenue growth, reiterated its full year guidance, and showed material... More

Dolby Laboratories (DLB) Tops Q1 EPS by 2c

January 27, 2016 4:17 PM EST

Dolby Laboratories (NYSE: DLB) reported Q1 EPS of $0.30, $0.02 better than the analyst estimate of $0.28. Revenue for the quarter came in at $240.8 million versus the consensus estimate of $239.14 million.

GUIDANCE:

Dolby Laboratories sees Q2 2016 EPS of $0.57-$0.63, versus the consensus of $0.90.... More